Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
Merck
AstraZeneca
McKesson
Johnson and Johnson
Colorcon

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

Meropenem - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for meropenem and what is the scope of freedom to operate?

Meropenem is the generic ingredient in four branded drugs marketed by Acs Dobfar, Acs Dobfar Spa, Amneal Pharms, Aurobindo Pharma Ltd, Daewoong Pharm Co, Gland Pharma Ltd, Hospira Inc, Hq Spclt Pharma, Sandoz, Savior Lifetec Corp, Pfizer, B Braun Medical Inc, and Rempex Pharms, and is included in thirteen NDAs. There are four patents protecting this compound. Additional information is available in the individual branded drug profile pages.

There are thirty-two drug master file entries for meropenem. Twelve suppliers are listed for this compound.

Drug Prices for meropenem

See drug prices for meropenem

Recent Clinical Trials for meropenem

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Virginia Commonwealth UniversityPhase 2
University of RwandaPhase 2
Postgraduate Institute of Medical Education and ResearchPhase 3

See all meropenem clinical trials

Pharmacology for meropenem
Synonyms for meropenem
(1R,5S,6S)-2-[(3S,5S)-5-(dimethylaminocarbonyl)pyrrolidin-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid
(1R,5S,6S)-2-[(3S,5S)-5-(dimethylaminocarbonyl)pyrrolidin-3-ylthio]-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid trihydrate
(1R,5S,6S)-2-[(3S,5S)-5-DIMETHYLAMINOCARBONYLPYRROLIDIN-3-YLTHIO]-6-[(R)-1-HYDROXYETHYL]-1-METHYLCARBAPEN-2-EM-3-CARBOXYLIC ACID
(4R,5S,6S)-3-(((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl)thio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4R,5S,6S)-3-((3S,5S)-5-(dimethylcarbamoyl)
(4R,5S,6S)-3-((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4R,5S,6S)-3-[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl-6-[(1S)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4R,5S,6S)-3-[[(3S,5S)-5-(dimethylaminocarbonyl)-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4R,5S,6S)-3-[[(3S,5S)-5-(Dimethylcarbamoyl)pyrrol
(4R,5S,6S)-3-[[(3S,5S)-5-(Dimethylcarbamoyl)pyrrolidin-3-yl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4R,5S,6S)-3-[[(3S,5S)-5-[(dimethylamino)carbonyl]-3-pyrrolidinyl]thio]-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4r,5s,6s)-3-{[(3s,5s)-5-(Dimethylcarbamoyl)pyrrolidin-3-Yl]sulfanyl}-6-[(1r)-1-Hydroxyethyl]-4-Methyl-7-Oxo-1-Azabicyclo[3.2.0]hept-2-Ene-2-Carboxylic Acid
(4R,5S,6S)-3-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]thio}-6-[(1R)-1-hydroxyethyl]-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(4R,6S)-3-((3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
(6S)-2-{[(3S,5S)-5-(dimethylcarbamoyl)pyrrolidin-3-yl]sulfanyl}-6-[(1R)-1-hydroxyethyl]-1beta-methyl-2,3-didehydro-1-carbapenam-3-carboxylic acid
[3.2.0]hept-2-ene-2-carboxylic acid
036M032
1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 3-(((3S,5S)-5-((dimethylamino)carbonyl)-3-pyrrolidinyl)thio)-6-((1R)-1-hydroxyethyl)-4-methyl-7-oxo-, (4R,5S,6S)-
119478-56-7
4-methyl-7-oxo-1-azabicyclo
96036-03-2
96036-03-2 (anhydr.)
AB0012458
AB00514051
AB00514051-02
AB00698370-05
AB1004614
AB2000075
AC1L9ALL
AJ-45665
AKOS015920140
AN-14469
Antibiotic SM 7338
BDBM50129062
BIDD:GT0851
BPBio1_001334
BR-50519
BSPBio_001212
CAS-96036-03-2
CCG-100850
CHEBI:43968
CHEMBL127
CPD000469184
CS-1865
CTK8G0800
D08185
DB00760
DMJNNHOOLUXYBV-PQTSNVLCSA-N
DSSTox_CID_25526
DSSTox_GSID_45526
DSSTox_RID_80930
DTXSID7045526
Epitope ID:195064
FT-0630992
HMS1571M14
HMS2051G08
HMS2090C05
HMS2098M14
HMS3715M14
HSDB 8019
HY-13678
ICI 194660
ICI-194660
J10087
KS-5224
M05727
M2279
MEPM
MERONEM
Meronem (TN)
Meropen
Meropenem (INN)
Meropenem [INN]
Meropenem anhydrous
Meropenem Hydrate
Meropenem trihydrate, Antibiotic for Culture Media Use Only
Meropenem,(S)
Meropenemum
Meropenemum trihydricum
Merrem
Merrem I.V. (TN)
Merrem IV
Merrem;Meronem
MFCD08600005
MLS001401437
MolPort-006-709-417
NC00100
NCGC00016962-01
NCGC00179259-01
NCGC00253670-01
NCGC00262579-02
Prestwick0_001106
Prestwick1_001106
Prestwick2_001106
Prestwick3_001106
PubChem17275
pyrrolidin-3-ylthio)-6-((R)-1-hydroxyethyl)-
S-3680
SAM001246650
SC-18058
SC-45234
SCHEMBL34442
SM 7338
SM-7338
SMR000469184
SPBio_003086
SR-01000762894
SR-01000762894-3
SR-01000762894-4
ST24025110
Tox21_110715
Tox21_110715_1
Tox21_113794
UNII-YOP6PX0BAO
YOP6PX0BAO
ZINC3808779

US Patents and Regulatory Information for meropenem

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Gland Pharma Ltd MEROPENEM meropenem INJECTABLE;INJECTION 206141-001 Jun 8, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Sandoz MEROPENEM meropenem INJECTABLE;INJECTION 091201-002 Mar 29, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz MEROPENEM meropenem INJECTABLE;INJECTION 091201-001 Mar 29, 2011 DISCN No No   Start Trial   Start Trial   Start Trial
Hospira Inc MEROPENEM meropenem INJECTABLE;INJECTION 090940-002 Jun 22, 2010 DISCN No No   Start Trial   Start Trial   Start Trial
Savior Lifetec Corp MEROPENEM meropenem INJECTABLE;INJECTION 206086-001 Apr 19, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Acs Dobfar Spa MEROPENEM meropenem INJECTABLE;INJECTION 204139-002 Jun 9, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
Acs Dobfar Spa MEROPENEM meropenem INJECTABLE;INJECTION 204139-001 Jun 9, 2016 AP RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Express Scripts
Boehringer Ingelheim
Dow
Colorcon
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.